Insulin aspart, recombinant Subcutaneous and Nivolumab Intravenous
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Nivolumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: nivolumab
Brand name: Opdivo
Synonyms: Nivolumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Nizatidine
- Insulin aspart, recombinant Subcutaneous-Nizatidine Capsules and Tablets
- Insulin aspart, recombinant Subcutaneous-Nizatidine Oral Solution
- Insulin aspart, recombinant Subcutaneous-Nizatidine Solution
- Insulin aspart, recombinant Subcutaneous-Nizoral
- Insulin aspart, recombinant Subcutaneous-No Doz Maximum Strength
- Nivolumab Intravenous-Insulin degludec
- Nivolumab Intravenous-Insulin Degludec (U-100) Prefilled Pens
- Nivolumab Intravenous-Insulin Degludec (U-100) Vials
- Nivolumab Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Nivolumab Intravenous-Insulin degludec and liraglutide
- Nivolumab Intravenous-Insulin degludec and liraglutide Subcutaneous